XML 19 R4.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Net Loss - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenue $ 1,780,093 $ 1,505,459
Cost of sales 634,796 505,107
Gross profit 1,145,297 1,000,352
Operating expenses:    
General and administrative expense 9,428,496 11,110,735
Operations expense 4,127,268 3,798,425
Sales and marketing expense 1,510,861 1,358,907
Loss on impairment of goodwill 0 7,231,093
Loss on impairment of finite-lived intangible assets 0 3,349,375
Loss on impairment of property and equipment 162,905 185,469
Total operating expenses 15,229,530 27,034,004
Total operating loss (14,084,233) (26,033,652)
Other income 152,776 185,646
Other expense (64,967) (5,275)
Gain on derivative instruments 12,457 115,647
Net loss $ (13,983,967) $ (25,737,634)
Net loss per common share – basic and diluted (in dollars per share) $ (3.48) $ (6.98)
Weighted average shares used in computation – basic and diluted (in shares) 4,014,848 3,685,954